期刊文献+

阿托伐他汀钙片和非诺贝特治疗混合型高脂血症疗效观察 被引量:1

原文传递
导出
作者 田中臣
出处 《医药论坛杂志》 2010年第17期123-124,共2页 Journal of Medical Forum
  • 引文网络
  • 相关文献

参考文献3

二级参考文献35

  • 1叶平.老年人血脂异常的特点及治疗[J].解放军保健医学杂志,2004,6(3):136-138. 被引量:8
  • 2宋文宣,王大鹏.C反应蛋白与冠心病[J].中国医刊,2004,39(8):8-11. 被引量:18
  • 3[3]中围成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[M]北京:人民卫生出版社.2007,6
  • 4Abdelmouttaleb I,Danchin N,Ilardo C,et al.C-Reactive protein and coronary artery disease:additional evidence of the implication of an inflammatory process in acute coronary syndromes[J].Am Heart J,1999,137(2):346-351.
  • 5Baker AH,Edwards DR,Murphy G,et al.Metalloproteinase inhibitors:biological actions and therapeutic opportunities[J].J Cell Sci,2002,115 (Pt 19):3719-3722.
  • 6Galis ZS,Johnson C,Godin D,et al.Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling[J].Circ Res,2002,91 (9):852-859.
  • 7Alfon J,Pueyo Palazon C,Royo T,et al.Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model[J].Thromb Haemost,1999,81(5):822-827.
  • 8Joukhadar C,Klein N,Prinz M,et al.Similar effects of atorvastatin,simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia[J].Thromb Haemost,2001,85 (1):47-51.
  • 9Tesfamariam B,Frohlich BH,Gregg RE.Differential effects of pravastatin,simvastatin and atorvastatin on Ca2+ release and vascular reactivity[J].J Cardiovasc Pharmacol,1999,34(1):95-101.
  • 10Katznelson S.Effect of HMG-CoA reductase inhibitors on chronic allograft rejection[J].Kidney Int Suppl,1999,71:S117-S121.

共引文献11

同被引文献10

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5233
  • 2Natarajan P, Ray KK, Cannon CP. High density lipoprotein and coronary heart disease: Current and future therapies. J Am Coll Cardiol,2010,55 : 1283-1299.
  • 3Chapman MJ, Redfern J S, McGovern ME, et al. Niacin and fi- brates in atherogenic dyslipidemia:Pharmacotherapy to reduce cardiovascular risk. Pharmacol Ther, 2010,126 : 314-345.
  • 4Wu YF,Liu XQ,Li X,et aL USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group, China Multicenter Collaborative Study of Cardiovascu-- lar Epidemiology Research Group. Estimation of ten-year risk of fatal and non-fatal ischemic cardiovascular diseases in Chi- nese. Circulation, 2006,114 z 2217-2225.
  • 5Reiner Z. Combined therapy in the treatment of dyslipidemia. Fundam Clin Pbarmacol, 2010,24 : 19-28.
  • 6Watts GF, Karpe F. Republished review: Triglycerides and atherugenie dyslipidaemia: Extending treatment beyond sta- tins in the high-risk cardiovascular patient. Postgrad Med J, 2011,87 : 776-782.
  • 7Baigent C,Iandray MJ,Reith C, et al. The e{feets of lowering LDL cholesterol with simvastatin plus ezetimihe in patients with chronic kidney disease (study of heart and renal protec-- tion): A randomised placebo-controlled trial. Lancet, 2011, 377:2181-2192.
  • 8刘恪英.联合降脂治疗的评价[J].中国医药指南(学术版),2008,6(8):83-86. 被引量:1
  • 9吴永杰.阿托伐他汀和阿昔莫司联合治疗高脂血症的临床观察[J].医药论坛杂志,2010,31(11):1-2. 被引量:4
  • 10胡大一.2010调脂治疗领域进展[J].中国新药杂志,2011,20(15):1358-1361. 被引量:10

引证文献1

二级引证文献6

;
使用帮助 返回顶部